Institutional Ownership Axsome Therapeutics, Inc. (AXSM)
This table provides information about the institutional ownership of Axsome Therapeutics, Inc. (AXSM). We have compiled data on the 406 institutions that hold shares in the stock, with a total of 36.1 Million shares, which have been reported (via 13F filing form) to have a value of $3.96 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
3,876,942
shares
|
$398 Million
0.01% of portfolio
|
Q1 2025
Reduced 0.65%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,299,991
shares
|
$338 Million
0.01% of portfolio
|
Q2 2024
Added 3.27%
|
|
|
Rtw Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
2,922,729
shares
|
$300 Million
5.58% of portfolio
|
Q1 2025
Reduced 27.86%
|
|
|
Bvf Inc
San Francisco, CA |
May 15, 2025 Q1 2025 |
1,690,221
shares
|
$173 Million
8.66% of portfolio
|
Q1 2025
Added 21.77%
|
|
|
Macquarie Group LTD
Australia, C3 |
May 15, 2025 Q1 2025 |
976,260
shares
|
$100 Million
0.14% of portfolio
|
Q1 2025
Added 1.27%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
934,853
shares
|
$95.9 Million
0.01% of portfolio
|
Q1 2025
Added 2.45%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
906,020
shares
|
$92.9 Million
0.0% of portfolio
|
Q1 2025
Reduced 4.35%
|
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
857,001
shares
|
$87.9 Million
0.02% of portfolio
|
Q1 2025
Added 23.76%
|
|
|
Fairmount Funds Management LLC
Philadelphia, PA |
May 15, 2025 Q1 2025 |
815,176
shares
|
$83.6 Million
32.39% of portfolio
|
Q1 2025
Reduced 44.51%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
May 15, 2025 Q1 2025 |
744,850
shares
|
$76.4 Million
1.84% of portfolio
|
Q1 2025
Reduced 10.12%
|
|
|
Wellington Management Group LLP
Boston, MA |
May 13, 2025 Q1 2025 |
703,279
shares
|
$72.1 Million
0.02% of portfolio
|
Q1 2025
New holding
|
|
|
Alethea Capital Management, LLC
San Diego, CA |
May 14, 2025 Q1 2025 |
667,368
shares
|
$68.4 Million
58.21% of portfolio
|
Q1 2025
Reduced 9.12%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
556,545
shares
|
$57.1 Million
5.2% of portfolio
|
Q1 2025
Added 19.07%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2025 Q1 2025 |
547,665
shares
|
$56.2 Million
0.06% of portfolio
|
Q1 2025
Added 2591.76%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
533,902
shares
|
$54.8 Million
0.01% of portfolio
|
Q1 2025
Added 160.97%
|
|
|
Man Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
513,221
shares
|
$52.6 Million
0.16% of portfolio
|
Q1 2025
Added 214.11%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
463,842
shares
|
$47.6 Million
0.04% of portfolio
|
Q2 2023
Added 13921.83%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
457,416
shares
|
$46.9 Million
0.0% of portfolio
|
Q1 2025
Reduced 20.71%
|
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
413,141
shares
|
$42.4 Million
0.02% of portfolio
|
Q1 2025
New holding
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
410,969
shares
|
$42.1 Million
0.01% of portfolio
|
Q1 2025
Added 2.1%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
386,700
shares
|
$39.7 Million
1.41% of portfolio
|
Q1 2025
New holding
|
|
|
1832 Asset Management L.P.
Toronto, A6 |
May 14, 2025 Q1 2025 |
363,200
shares
|
$37.2 Million
0.09% of portfolio
|
Q1 2025
New holding
|
|
|
Perceptive Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
355,107
shares
|
$36.4 Million
1.73% of portfolio
|
Q1 2025
Reduced 46.53%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
337,246
shares
|
$34.6 Million
0.01% of portfolio
|
Q1 2025
Added 2.81%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 05, 2025 Q1 2025 |
333,205
shares
|
$34.2 Million
0.05% of portfolio
|
Q1 2025
Added 7022.81%
|